Clinical Trial Update: PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update summarizes the Phase 1/2 results of oral ixazomib in combination with chemotherapy for pediatric patients with relapsed or refractory…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Lymphoblastic Lymphoma

Drugs mentioned

• NINLARO (ixazomib)

Snippet

Sponsor: Therapeutic Advances in Childhood Leukemia Consortium | Conditions: ALL, Childhood, Lymphoblastic Lymphoma, Childhood | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2025-06-17